TACI-Fc gene therapy improves autoimmune sialadenitis but not salivary gland function in non-obese diabetic mice

Absence of up-regulation for a proliferation-inducing ligand in Sjogren's sialadenitis lesions

(2011) T. Lombardi et al.   RHEUMATOLOGY

Cytokines in Sjogren's syndrome: potential therapeutic targets

(2010) N. Roescher et al.   ANNALS OF THE RHEUMATIC DISEASES

Effectiveness of rituximab treatment in primary Sjögren's syndrome: A randomized, double-blind, placebo-controlled trial

(2010) J. M. Meijer et al.   ARTHRITIS AND RHEUMATISM

Minor salivary gland immunohistology in the diagnosis of primary Sjögren’s syndrome

(2010) Stina Salomonsson et al.   JOURNAL OF ORAL PATHOLOGY & MEDICINE

Interleukin-12 induces salivary gland dysfunction in transgenic mice, providing a new model of Sjögren's syndrome

(2009) Jelle L. Vosters et al.   ARTHRITIS AND RHEUMATISM

Sjögren syndrome: Advances in the pathogenesis from animal models

(2009) J.A. Chiorini et al.   JOURNAL OF AUTOIMMUNITY

An exploratory dose-escalating study investigating the safety, tolerability, pharmacokinetics and pharmacodynamics of intravenous atacicept in patients with systemic lupus erythematosus

(2009) C Pena-Rossi et al.   LUPUS

Local expression of tumor necrosis factor-receptor 1:immunoglobulin G can induce salivary gland dysfunction in a murine model of Sjögren's syndrome

(2009) Jelle L Vosters et al.   ARTHRITIS RESEARCH & THERAPY

Serum levels of tumour necrosis factor family members a proliferation-inducing ligand (APRIL) and B lymphocyte stimulator (BLyS) are inversely correlated in systemic lupus erythematosus

(2008) J Morel et al.   ANNALS OF THE RHEUMATIC DISEASES

BAFF enhances chemotaxis of primary human B cells: a particular synergy between BAFF and CXCL13 on memory B cells

(2008) G. Badr et al.   BLOOD